Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/SPERO-THERAPEUTICS-INC-38533873/news/GSK-plc-und-Spero-Therapeutics-Inc-kundigen-exklusive-Lizenzvereinbarung-fur-Tebipenem-HBr-an-41844899/?utm_source=whatsapp&utm_medium=social&utm_campaign=share